Related Experiment Videos

[Benefits and risks of topical steroids in childhood]

F H Sennhauser1

  • 1Pädiatrische Pneumologie, Ostschweizerisches Kinderspital St. Gallen.

Schweizerische Medizinische Wochenschrift
|March 11, 1995
PubMed

Insights

Inhaled glucocorticosteroids are key for childhood asthma but may cause systemic side effects. This review details risks, benefits, and best practices for using inhaled steroids safely in children.

Area of Science:

  • Pediatric Pulmonology
  • Pharmacology
  • Endocrinology

Context:

  • Inhaled glucocorticosteroids (IGCs) are primary anti-inflammatory agents for pediatric asthma.
  • Concerns exist regarding potential systemic effects of IGCs, including growth, bone metabolism, and adrenal function.

Purpose:

  • To review current literature on the clinical efficacy and safety of IGCs in children.
  • To highlight potential side effects, optimal dosing, and inhalation techniques.
  • To guide practitioners on appropriate indications and therapeutic strategies.

Summary:

  • IGCs are effective for childhood asthma but require careful monitoring for systemic effects.
  • Dose and inhalation technique significantly influence the risk-benefit profile.
  • This review synthesizes data to support informed clinical decision-making.

Impact:

  • Provides essential information for healthcare professionals managing pediatric asthma with IGCs.
  • Facilitates evidence-based discussions on IGC safety with patients and families.
  • Aims to optimize therapeutic outcomes while minimizing adverse events in children.

Related Concept Videos